Skip to main content
NANOVEU LIMITED logo

NANOVEU LIMITED — Investor Relations & Filings

Ticker · NVU ISIN · AU0000024796 LEI · 5299003PDOQ5DPU98119 ASX Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2021-11-09 Investor Presentation
Country AU Australia
Listing ASX NVU

About NANOVEU LIMITED

https://nanoveu.com/

Nanoveu Limited specializes in the development of advanced materials and digital imaging solutions through nanotechnology. The company’s product portfolio includes EyeFly3D, a specialized film and software platform that enables glasses-free 3D visualization on mobile devices. Its Nanoshield product line features antimicrobial coatings and films that utilize copper ions to eliminate pathogens on frequently touched surfaces. Furthermore, the company is advancing EyeFyx technology, which aims to provide vision correction for individuals with presbyopia by manipulating digital screen output. Nanoveu focuses on integrating proprietary thin-film coatings with sophisticated algorithms to enhance display functionality and provide protective surface treatments across various consumer and commercial applications.

Recent filings

Filing Released Lang Actions
Investor Webinar Presentation 22 pages 1.4MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Webinar Presentation' and is described as a presentation delivered during a webinar to shareholders and investors. It contains detailed company overview, product descriptions, management team bios, market analysis, and investment highlights. The document is an investor presentation focused on financials, strategy, and market position rather than a formal regulatory filing or financial report. It is not an annual report, earnings release, or management discussion. The presence of the phrase 'Investor Presentation' and the content style clearly indicate it is an investor presentation document.
2021-11-09 English
Strategic License and Supply Agreement with Cupron, Inc. 3 pages 67.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 9 November 2021 announcing a Strategic License and Supply Agreement between Nanoveu Limited and Cupron, Inc. It details the terms of the agreement, product information, and includes commentary from the company's chairman. The document is a corporate announcement about a business agreement and does not contain financial statements, earnings data, or regulatory filings. It is not a report, transcript, or voting result. The content fits best under Capital/Financing Update (CAP) as it relates to a strategic commercial agreement impacting product supply and growth prospects, which is a form of business update related to company operations and potential capital impact. The document length is 6776 characters, which is consistent with a detailed announcement rather than a full report.
2021-11-08 English
Investor Webinar 2 pages 45.7KB
Investor Presentation Classification · 90% confidence The document is an ASX release dated 9 November 2021 announcing an upcoming investor webinar where the CEO will present an updated Investor Presentation followed by a Q&A session. It includes details about the event, registration link, and contact information. The document does not contain financial statements, detailed financial analysis, or full transcript of the webinar. It is essentially an announcement of an investor presentation event rather than the presentation itself or a financial report. The document length is 2917 characters, which is relatively short and consistent with an announcement. Therefore, the most appropriate classification is Investor Presentation (IP) as it relates to the presentation content and investor communication, not a full report or transcript.
2021-11-08 English
Results of Meeting 2 pages 140.9KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX release titled 'Results of General Meeting' for Nanoveu Limited, dated 8 November 2021. It provides detailed voting results of resolutions passed at a General Meeting held on 8 October 2021. The content includes resolution descriptions, voting methods, and vote counts. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting. The document is short (1815 characters) and focused solely on voting results, not a full report or announcement of a report publication. Therefore, it is classified as DVA.
2021-11-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 2.0MB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX release dated 29 October 2021 titled 'Quarterly Activities Report and Appendix 4C for the Quarter Ended 30 September 2021'. It provides a detailed overview of the company's activities during the quarter, including product developments, agreements, capital raising, and management changes. It also includes an Appendix 4C, which is a quarterly cash flow report commonly required by the ASX for listed companies. The document contains substantive financial and operational data for the quarter, not just an announcement or a brief summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements or substantive financial data and analysis. Q3 2021
2021-10-28 English
Licensing Agreement with NTU Singapore 5 pages 299.1KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing a Licensing and Research Collaboration Agreement between Nanoveu Limited and Nanyang Technological University Singapore. It details the development of a new antiviral and antibacterial spray product, testing results, and strategic partnership information. There are no financial statements, quarterly or annual results, or regulatory certifications. The document is a corporate announcement about a licensing agreement and product development progress, typical of a Capital/Financing Update or strategic business update. It is not an earnings release, annual report, or regulatory filing. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2021-10-13 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.